Cargando…
Structural Identification of Zotarolimus (ABT-578) Metabolites Generated by Human Liver Microsomes Using Ion-Trap and High-Resolution Time-of-Flight Mass Spectrometry in Combination with the Analysis of Fragmentation Patterns
Zotarolimus (ABT-578) is a sirolimus derivative that, like sirolimus and everolimus, is an inhibitor of cell growth via inhibition of the mechanistic target of rapamycin (mTOR). Zotarolimus was developed for coating coronary stents to prevent smooth muscle cell proliferation and restenosis. Albeit z...
Autores principales: | Shokati, Touraj, Drake, Seth H., Zhao, Wanzhu, Klawitter, Jost, Klawitter, Jelena, Christians, Uwe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10608723/ https://www.ncbi.nlm.nih.gov/pubmed/37887418 http://dx.doi.org/10.3390/metabo13101093 |
Ejemplares similares
-
Effects of lovastatin on breast cancer cells: a proteo-metabonomic study
por: Klawitter, Jelena, et al.
Publicado: (2010) -
Mycophenolate Mofetil Enhances the Negative Effects of Sirolimus and Tacrolimus on Rat Kidney Cell Metabolism
por: Klawitter, Jelena, et al.
Publicado: (2014) -
Everolimus and Sirolimus in Combination with Cyclosporine Have Different Effects on Renal Metabolism in the Rat
por: Bohra, Rahul, et al.
Publicado: (2012) -
Mitochondrial cyclophilin D ablation is associated with the activation of Akt/p70S6K pathway in the mouse kidney
por: Klawitter, Jelena, et al.
Publicado: (2017) -
Metabolic profiling in children and young adults with autosomal dominant polycystic kidney disease
por: Baliga, Madhurima M., et al.
Publicado: (2021)